Drug Shortage Report for TWINRIX

Last updated on 2019-10-22 History
Report ID 83033
Drug Identification Number 02230578
Brand name TWINRIX
Common or Proper name Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN
Strength(s) 720UNIT 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-01
Estimated end date 2019-11-14
Actual end date 2019-10-21
Shortage status Resolved
Updated date 2019-10-22
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2019-10-22 English Compare
v16 2019-10-21 French Compare
v15 2019-10-21 English Compare
v14 2019-10-10 French Compare
v13 2019-10-10 English Compare
v12 2019-10-02 French Compare
v11 2019-10-02 English Compare
v10 2019-09-11 French Compare
v9 2019-09-11 English Compare
v8 2019-08-16 French Compare
v7 2019-08-16 English Compare
v6 2019-08-09 French Compare
v5 2019-08-09 English Compare
v4 2019-07-19 French Compare
v3 2019-07-19 English Compare
v2 2019-05-03 French Compare
v1 2019-05-03 English Compare